Berlin - Delayed Quote EUR

Celsion Corp (CBO.BE)

1.6100
+0.0300
+(1.90%)
As of 8:08:18 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
500
500
Operating Expense
18,266.2990
19,132.4460
21,030.4300
25,421.5650
21,507.1900
Operating Income
-18,266.2990
-19,132.4460
-21,030.4300
-24,921.5650
-21,007.1900
Net Non Operating Interest Income Expense
--
450.2210
528.7440
-4,526.0400
-551.7360
Other Income Expense
22.8660
61.9830
-293.6760
-8,017.6550
-593.7700
Pretax Income
-17,793.2120
-18,620.2420
-20,795.3620
-37,465.2600
-22,152.6960
Tax Provision
--
0
-1,280.3850
-1,567.0260
-1,383.4460
Net Income Common Stockholders
-17,793.2120
-18,620.2420
-19,514.9770
-35,898.2340
-20,769.2500
Diluted NI Available to Com Stockholders
-17,793.2120
-18,620.2420
-19,514.9770
-35,898.2340
-20,769.2500
Basic EPS
-1.38
-1.62
-2.16
-5.03
-3.83
Diluted EPS
-1.38
-1.62
-2.16
-5.03
-3.83
Basic Average Shares
12,797.7480
11,508.1590
9,045.3200
7,143
5,424.3140
Diluted Average Shares
12,797.7480
11,508.1590
9,045.3200
7,143
5,424.3140
Total Operating Income as Reported
-18,266.2990
-19,132.4460
-21,030.4300
-24,921.5650
-21,007.1900
Total Expenses
18,266.2990
19,132.4460
21,030.4300
25,421.5650
21,507.1900
Net Income from Continuing & Discontinued Operation
-17,793.2120
-18,620.2420
-19,514.9770
-35,898.2340
-20,769.2500
Normalized Income
-17,816.0780
-18,682.2250
-19,611.3588
-28,207.5757
-20,210.5125
Interest Income
--
450.2210
725.8240
502.5780
18.1450
Interest Expense
--
0
197.0800
5,028.6180
569.8810
Net Interest Income
--
450.2210
528.7440
-4,526.0400
-551.7360
EBIT
-17,754.0950
-18,620.2420
-20,598.2820
-32,436.6420
-21,582.8150
EBITDA
-17,016.3620
-17,902.1260
-19,878.2770
-31,705.0130
-20,879.8970
Reconciled Depreciation
737.7330
718.1160
720.0050
731.6290
702.9180
Net Income from Continuing Operation Net Minority Interest
-17,793.2120
-18,620.2420
-19,514.9770
-35,898.2340
-20,769.2500
Total Unusual Items Excluding Goodwill
22.8660
61.9830
102.6430
-8,019.4560
-595.6690
Total Unusual Items
22.8660
61.9830
102.6430
-8,019.4560
-595.6690
Normalized EBITDA
-17,039.2280
-17,964.1090
-19,980.9200
-23,685.5570
-20,284.2280
Tax Rate for Calcs
0
0
0.0001
0
0.0001
Tax Effect of Unusual Items
0
0
6.2612
-328.7977
-36.9315
12/31/2021 - 3/1/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

0Z2.MU Alector Inc
1.2600
-1.56%
 
YB4P.DU Savara Inc
1.8900
+1.07%
 
LEXX Lexaria Bioscience Corp.
1.0350
+1.47%
 
INTS Intensity Therapeutics, Inc.
0.3890
+24.00%
 
CNSP CNS Pharmaceuticals, Inc.
1.0700
+1.90%
 
KLTO Klotho Neurosciences, Inc.
0.1915
-8.81%
 
ABP Abpro Holdings, Inc.
0.2330
-9.16%
 
IPA ImmunoPrecise Antibodies Ltd.
0.5742
+2.87%
 
CDT Conduit Pharmaceuticals Inc.
3.6200
-1.90%
 
NRXS NeurAxis, Inc.
2.8600
+2.14%